Malnique, F. et al. 2025. COMBINATION THERAPY WITH ROSUVASTATIN AND EZETIMIBE (TREZETE) IN VERY HIGH CARDIOVASCULAR RISK DYSLIPIDEMIA: EVIDENCE OF EFFICACY AND CLINICAL IMPACT. LUMEN ET VIRTUS. 16, 54 (Nov. 2025), e9720 . DOI:https://doi.org/10.56238/levv16n54-030.